Bio-Techne posts revenue gains in Q3

By The Science Advisory Board staff writers

May 6, 2021 -- Bio-Techne reported strong growth in revenues for its third quarter (end-March 31), thanks largely to sales in its protein analysis business.

For the third quarter, Bio-Techne posted revenue of $243.6 million, up 22% compared to last year, with foreign currency exchange having a favorable effect of 3%.

For the first nine months of fiscal year 2021, the company reported revenue of $672 million, up 17% compared to last year.

Additionally, the company reported net sales of its protein sciences segment, which provides an array of platforms useful in various areas of protein analysis, were $185.6 million, a record increase of 28% from $145.5 million for the third quarter of fiscal 2020, according to a release.

Copyright © 2021
To access all The ScienceBoard content create a free account now:

Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.
I have read and agree to the privacy policy and terms of service and wish to opt-in for

Already have an account? Sign in here